MedPath

三普药业有限公司

Ownership
-
Established
2013-08-14
Employees
-
Market Cap
-
Website
sqg.sanpuzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

NMPA:30

Drug Approvals

牛黄镇惊丸

Approval Number
国药准字Z63020099
Approval Date
Apr 15, 2020
NMPA

健脾丸

Approval Number
国药准字Z63020109
Approval Date
Apr 15, 2020
NMPA

跌打丸

Approval Number
国药准字Z63020106
Approval Date
Apr 15, 2020
NMPA

加减地黄丸

Approval Number
国药准字Z63020088
Approval Date
Apr 15, 2020
NMPA

金锁固精丸

Approval Number
国药准字Z63020033
Approval Date
Apr 15, 2020
NMPA

养荣丸

Approval Number
国药准字Z63020025
Approval Date
Apr 15, 2020
NMPA

八宝坤顺丸

Approval Number
国药准字Z63020015
Approval Date
Apr 14, 2020
NMPA

牛黄解毒丸

Approval Number
国药准字Z63020098
Approval Date
Apr 14, 2020
NMPA

朱砂安神丸

Approval Number
国药准字Z63020093
Approval Date
Apr 14, 2020
NMPA

十全大补丸

Approval Number
国药准字Z63020123
Approval Date
Apr 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.